| 國立臺灣大學 |
1995 |
Cytogenetic Study of Mentally Retarded Children in Taipei
|
Sheng, W. W.; Lai, Y. M.; 胡務亮; Wang, T. R.; Wuu, K. I.; Sheng, W. W.; Lai, Y. M.; Hwu, Wuh-Liang; Wang, T. R.; Wuu, K. I. |
| 臺大學術典藏 |
2020-12-16T02:26:29Z |
Cytogenetic study of mentally retarded children in Taipei
|
Wang-Wuu S.; Lai Y.-M.; WUH-LIANG HWU; Wang T.-R.; Wuu K.-D. |
| 國立臺灣大學 |
1994 |
Cytogenetic Study of Spontaneous Abortions with the Giemsa Banding Method
|
Tseng, Li-Hui; 何弘能; 柯滄銘; Tseng, Li-Hui; Ho, Hong-Nerng; Ko, Tsang-Ming |
| 國立臺灣大學 |
1994 |
Cytogenetic study of spontaneous abortions with the giemsa banding method
|
華筱玲; 曾麗慧; 何弘能; 柯滄銘; HWA, HSIAO-LIN; TSENG, LI-HUI; HO, HONG-NERNG; KO, TSANG-MING |
| 臺大學術典藏 |
2018-09-10T04:42:48Z |
Cytogenetic study of spontaneous abortions with the Giemsa banding method.
|
Hwa, H.L. and Tseng, L.H. and Ho, H.N. and Ko, T.M.; HSIAO-LIN HWA |
| 臺大學術典藏 |
2018-09-10T04:46:10Z |
Cytogenetic study of spontaneous abortions with the Giemsa banding method.
|
Hwa, H.L.;Tseng, L.H.;Ho, H.N.;Ko, T.M.; LI-HUI TSENG |
| 臺大學術典藏 |
2018-09-10T05:03:40Z |
Cytogenetic study of spontaneous abortions with the Giemsa banding method.
|
Hwa, H.L. and Tseng, L.H. and Ho, H.N. and Ko, T.M.; HONG-NERNG HO |
| 臺大學術典藏 |
2020-02-03T08:15:28Z |
Cytogenetic study of spontaneous abortions with the Giemsa banding method.
|
HSIAO-LIN HWA; Tseng L.H.; Ho H.N.; Ko T.M. |
| 臺大學術典藏 |
2020-02-17T07:44:11Z |
Cytogenetic study of spontaneous abortions with the Giemsa banding method.
|
Hwa H.L; Tseng L.H; HONG-NERNG HO; Ko T.M. |
| 臺大學術典藏 |
2022-03-10T07:58:59Z |
Cytogenetic study of spontaneous abortions with the Giemsa banding method.
|
Hwa H.L.; LI-HUI TSENG; Ho H.N.; Ko T.M. |
| 亞洲大學 |
2000 |
Cytogenetic study of workers exposed to chromium compounds
|
Fang-Yang Wu;Fuu-Jen Tsai;Hsien-Wen Kuo;Chang-Hai Tsai;Wu-Yui Wu;Ruey-Yun Wang;Lai Jim-Shoung |
| 中國醫藥大學 |
2000 |
Cytogenetic study of workers exposed to chromium compounds
|
吳芳鴦(Fang-Yang Wu); 蔡輔仁(Fuu-Jen Tsai); 郭憲文(Hsien-Wen Kuo); 蔡長海(Chang-Hai Tsai); (Wu-Yui Wu); 王瑞筠(Ruey-Yun Wang); 賴俊雄 |
| 中國醫藥大學 |
2000 |
Cytogenetic study of workers exposed to chromium compounds
|
Wu, FY; Tsai, FJ; Kuo, HW; Tsai, CH; Wu, WY; Wang, RY; Lai, JS |
| 國立成功大學 |
2004-03 |
Cytogenetic surveillance of mentally-retarded school children in southern Taiwan
|
Shiue, Chiou-Nan; Lin, Ying-Hui; Kuan, Long-Ching; Lii, Li-Miin; Tsai, Wen-Hui; Chen, Yann-Jan; Lin, Shio-Jean; Kuo, Pao-Lin |
| 中國醫藥大學 |
2007.09 |
Cytogenetic variability in the proportion of abnormal cells between the various tissues in prenatally detected mosaic tetrasomy 12p
|
陳持平(Chen CP)*; 蔡輔仁(Fuu-Jen Tsai); (Chern SR); (Lee CC); (Town DD); (Wang W) |
| 中國醫藥大學 |
2007.09 |
Cytogenetic variability in the proportion of abnormal cells between the various tissues in prenatally detected mosaic tetrasomy 12p
|
陳持平(Chen CP)*; 蔡輔仁(Fuu-Jen Tsai); (Chern SR); (Lee CC); (Town DD); (Wang W) |
| 臺大學術典藏 |
2020-09-29T16:47:19Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, YW; Tsai, CH; Lin, CC; Tien, FM; Chen, YW; HSIN-YI LIN; Yao, M; Lin, YC; Lin, CT; Cheng, CL; Tang, JL; Chou, WC; Hou, HA; Tien, HF |
| 臺大學術典藏 |
2020-10-28T08:35:05Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; CHENG-HONG TSAI; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F.; Yao M.; Lin H.-Y. |
| 臺大學術典藏 |
2020-12-09T00:46:09Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, Yu-Wen; Tsai, Cheng-Hong; Lin, Chien-Chin; Tien, Feng-Ming; Chen, Yu-Wen; Lin, Hsing-Yu; MING YAO; Lin, Yun-Chu; Lin, Chien-Ting; Chieh-Lung Cheng; Tang, Jih-Luh; Chou, Wen-Chien; Hou, Hsin-An; Tien, Hwei-Fang |
| 臺大學術典藏 |
2021-01-04T12:12:16Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Lin C.-C.; Wang Y.-W.; Tsai C.-H.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2020 |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Hou H.-A.; Chou W.-C.; Tang J.-L.; Cheng C.-L.; Lin C.-T.; Lin Y.-C.; MING YAO; Lin H.-Y.; Chen Y.-W.; Tien F.-M.; Lin C.-C.; Tsai C.-H.; Wang Y.-W.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:30Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; LIN YUN-CHU; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; TIEN FENG-MING; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:17Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; JIH-LUH TANG; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:11Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.;Tsai C.-H.;Lin C.-C.;Tien F.-M.;Chen Y.-W.;Lin H.-Y.;Yao M.;Lin Y.-C.;Lin C.-T.;Cheng C.-L.;Tang J.-L.;Wen-Chien Chou;Hou H.-A.;Tien H.-F.; Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; WEN-CHIEN CHOU; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; FENG-MING TIEN; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 國立臺灣大學 |
2006 |
Cytogenetics in Childhood Acute Lymphoblastic Leukemia in Taiwan: A Single-Institutional Experience
|
張修豪; 盧孟佑; 周獻堂; 林凱信; 林東燦; 田蕙芬; CHANG, HSIU-HAO; LU, MENG-YAO; JOU, SHIANN-TARNG; LIN, KAI-HSIN; LIN, DONG-TSAMN; TIEN, HWEI-FANG |
| 國立臺灣大學 |
2006-06 |
CYTOGENETICS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN TAIWAN: A Single-Institutional Experience
|
張修豪; 盧孟佑; 周獻堂; 林凱信; 林東燦; 田蕙芬; 林東燦 |
| 臺大學術典藏 |
2020-12-16T07:22:02Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Chang H.-H.;Meng-Yao Lu;Jou S.-T.;Lin K.-H.;Tien H.-F.;Lin D.-T.; Chang H.-H.; MENG-YAO LU; Jou S.-T.; Lin K.-H.; Tien H.-F.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-18T05:28:49Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Lin D.-T.; HSIU-HAO CHANG; Lu M.-Y.; Jou S.-T.; Lin K.-H.; Tien H.-F.; Hsiu-Hao Chang;Lu M.-Y.;Jou S.-T.;Lin K.-H.;Tien H.-F.;Lin D.-T. |
| 臺大學術典藏 |
2021-01-04T12:12:56Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Chang H.-H.; Lu M.-Y.; Jou S.-T.; Lin K.-H.; HWEI-FANG TIEN; Lin D.-T. |
| 臺大學術典藏 |
2021-01-05T02:29:02Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Lin D.-T.; Tien H.-F.; Lin K.-H.; SHIANN-TANG JOU; Lu M.-Y.; Chang H.-H.; Chang H.-H.;Lu M.-Y.;Shiann-Tang Jou;Lin K.-H.;Tien H.-F.;Lin D.-T. |
| 國立臺灣大學 |
1994 |
Cytogenetics studies on Saccharum-Miscanthus Nobilization.
|
Cheng, H-H; Wen, Y-Y; Chen, C |
| 臺北醫學大學 |
2013 |
Cytogenic and molecular analyses of 46,XX male syndrome with clinical comparison to other groups with testicular azoospermia of genetic origin
|
Chiang, HS;Wu, YN;Wu, CC;Hwang, JL |
| 臺北醫學大學 |
2013 |
Cytogenic and molecular analyses of 46,XX male syndrome with clinical comparison to other groups with testicular azoospermia of genetic origin
|
HS, Chiang;YN, Wu;CC, Wu;JL, Hwang |
| 國家衛生研究院 |
2021-04-23 |
Cytoguardin: A tryptophan metabolite against cancer growth and metastasis
|
Wu, KK |
| 國家衛生研究院 |
2014-12-08 |
cytoHubba: Identifying hub objects and sub-networks from complex interactome
|
Chin, CH;Chen, SH;Wu, HH;Ho, CW;Ko, MT;Lin, CY |
| 東海大學 |
2011-04 |
Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells.
|
趙偉廷; Liu, Yi-Hsiang; Ho, Chin-Chin; Cheng, Chiung-Chi; Chao, Wei-Ting; Pei, Ren-Jeng; Hsu, Yung-Hsiang; Lai, Yih-Shyong |
| 高雄醫學大學 |
1996 |
Cytokeratin Fragment 19 (CYFRA 21-1) as a Tumor Marker in Non-Small Cell Lung Cancer
|
黃明賢;鍾相彬;林茂生;鍾飲文;蔡米山;林秀純;黃吉志 ; Huang, MS;Jong, SB;Lin, MS;Chong, IW;Tsai, MS;Lin, HC;Hwang, JJ |
| 高雄醫學大學 |
1996 |
Cytokeratin Fragment 19 (CYFRA 21-1) as a Tumor Marker in Non-Small Cell Lung Cancer.
|
黃明賢, 鍾相彬,林茂生,鍾飲文,蔡米山,林秀純,黃吉志?; Huang MS, SB Jong, MS Lin, IW Chong, MS Tsai, HC Lin and JJ Hwang.? |
| 高雄醫學大學 |
1996 |
Cytokeratin Fragment 19 (CYFRA 21-1) as a Tumor Marker in Non-Small Cell Lung Cancer.
|
黃明賢;鍾相彬;林茂生;鍾飲文;蔡米山;林秀純;黃吉志; Huang, MS;Jong, SB;Lin, MS;Chong, IW;Tsai, MS;Lin, HC;JJ, Hwang. |
| 中國醫藥大學 |
1999 |
Cytokeratin fragment 19 (CYFRA 21-1) in healthy smokers
|
Kao, CH; Hsieh, JF; Ho, YJ; Tsai, SC; Lee, JK |
| 中國醫藥大學 |
1999 |
Cytokeratin fragment 19 (CYFRA 21-1) in healthy smokers
|
Kao, CH; Hsieh, JF; Ho, YJ; Tsai, SC; Lee, JK |
| 中國醫藥大學 |
2000 |
Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma
|
Sun, SS; Hsieh, JF; Tsai, SC; Ho, YJ; Lee, JK; Kao, CH |
| 國家衛生研究院 |
1997-02 |
Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells
|
Yuan, CC; Huang, HC; Tsai, LC; Ng, HT; Huang, TS |
| 嘉南藥理大學 |
2009 |
Cytokine
|
Elsevier SDOL |
| 嘉南藥理大學 |
2009 |
Cytokine & Growth Factor Reviews
|
Elsevier SDOL |
| 亞洲大學 |
2008-07 |
Cytokine (IL-6) and chemokine (IL-8) gene polymorphisms among rheumatoid arthritis patients in Taiwan
|
Lo, SF;Lo, S. -F.; Huang, CM ;Huang, C. -M.; Lin, HC ;Lin, H. -C.; Chen, WC ;Chen, W. -C.; Tsai, CH ;Tsai, C. -H.; Tsai, FJ ;Tsai, F. -J. |
| 臺北醫學大學 |
2002 |
Cytokine and Endometriosis
|
hong-Nerng Ho,M.D. |
